{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:45:54Z","timestamp":1759797954253,"version":"build-2065373602"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bull Exp Biol Med"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10517-025-06479-8","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T07:28:59Z","timestamp":1758785339000},"page":"305-311","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Class III Antiarrhythmic Drug Cavutilide Does Not Increase the Susceptibility of the Ventricles to Phenylephrine-Induced Tachyarrhythmias Due to the Direct Dependence of the Effect on the Frequency of Myocardial Activation"],"prefix":"10.1007","volume":"179","author":[{"given":"V. S.","family":"Kuzmin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. A.","family":"Abramov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu. V.","family":"Egorov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. V.","family":"Abramochkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"6479_CR1","unstructured":"Yuricheva YuA, Maykov EB, Sokolov SF, et al. First experience of clinical use of new class III antiarrhythmic agent Niferidil in patients with persistent atrial fibrillation and flutter. Cardiology (Moskva). 2011;51(1):55-64. Russian."},{"key":"6479_CR2","unstructured":"Yuricheva YuA, Maykov EB, Sokolov SF, et al. Efficacy and safety of new class III antiarrhythmic agent Niferidil in reduction of persistent atrial fibrillation and flutter. Russian Cardiology Bulletin. 2011;6(1):5-15. Russian."},{"key":"6479_CR3","unstructured":"Mironov NYu, Golitsyn SP, Sokolov SF, et al. Electrophysiological effects and antiarrhythmic activity of novel domestic class III antiarrhythmogenic drug Niferidil administered in patients with paroxismal supraventricular tachycardia. Experimental and Clinical Pharmacology. 2012;75(10):16-21. Russian."},{"issue":"3","key":"6479_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/FJC.0000000000000112","volume":"64","author":"EB Maykov","year":"2014","unstructured":"Maykov E.B., Yuricheva Y.A., Mironov N.Y., et al. Efficacy of a new class III drug Niferidil in cardioversion of persistent atrial fibrillation and flutter. J Cardiovasc Pharmacol. 2014;64(3):247-55. https:\/\/doi.org\/10.1097\/FJC.0000000000000112","journal-title":"J Cardiovasc Pharmacol."},{"key":"6479_CR5","doi-asserted-by":"publisher","unstructured":"Glushkov RG, Yuzhakov SD, L\u2019vov AI, et al. New group of class III antiarrhythmic drugs: piperidin-4-yl ethane derivatives. Pharm Chem J. 2011;45(2):65-74. https:\/\/doi.org\/10.1007\/s11094-011-0562-6","DOI":"10.1007\/s11094-011-0562-6"},{"issue":"5\u20136","key":"6479_CR6","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s10557-017-6762-x","volume":"31","author":"DV Abramochkin","year":"2017","unstructured":"Abramochkin DV, Kuzmin VS, Rosenshtraukh LV. A New class III antiarrhythmic drug Niferidil prolongs action potentials in Guinea pig atrial myocardium via inhibition of rapid delayed rectifier. Cardiovasc Drugs Ther. 2017;31(5-6):525-33. https:\/\/doi.org\/10.1007\/s10557-017-6762-x","journal-title":"Cardiovasc Drugs Ther."},{"key":"6479_CR7","unstructured":"Resnik AV, Fedorov VV, Kokoz YuM, et al. Ionic mechanisms of cardiotropic action of a new class III antiarrhythmic drug RG-2. Cardiology (Moskva). 2003;43(10):76-81. Russian."},{"key":"6479_CR8","unstructured":"Fedorov VV, Ivanova IA, Glukhov AV, et al. Anticholinergic effect of a new antiarrhythmic class III drug RG-2. Cardiology (Moskva). 2004;44(7):62-6. Russian."},{"issue":"10","key":"6479_CR9","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00210-015-1146-x","volume":"388","author":"DV Abramochkin","year":"2015","unstructured":"Abramochkin DV, Kuzmin VS, Rosenshtraukh LV, et al. Effects of new class III antiarrhythmic drug Niferidil on electrical activity in murine ventricular myocardium and their ionic mechanisms. Naunyn Schmiedebergs Arch Pharmacol. 2015;388(10):1105-12. https:\/\/doi.org\/10.1007\/s00210-015-1146-x","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"6479_CR10","unstructured":"Fedorov VV, Rosenshtraukh LV, Resnik AV, et al. Antiarrhythmic efficacy of a new class III antiarrhythmic drug RG-2. Cardiology (Moskva). 2004;44(11):66-73. Russian."},{"key":"6479_CR11","unstructured":"Rosenshtraukh LV, Fedorov VV, Reznik AV, et al. Electrophysiological experimental study of a novel class III antiarrhythmic drug RG-2. Cardiology (Moskva). 2003;43(9):56-63. Russian."},{"key":"6479_CR12","unstructured":"Rosenstrauch LV, Chazov YeI, Glushkov RG, et al. Development of original Russian antiarrhythmic drugs of the 3rd class. Annals of the Russian Academy of Medical Sciences. 2003;(12):65. Russian."},{"key":"6479_CR13","unstructured":"Egorov YuV, Stolbova VI, Kuzmin VS, et al. Influence of a novel class ii antiarrhythmic drug Niferidil (RG-2) on bioelectrical activity of rat pulmonary veins myocardium. Cardiology (Moskva). 2012;52(2):47-51. Russian."},{"issue":"3","key":"6479_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/cvr\/27.3.349","volume":"27","author":"L Ver Donck","year":"1993","unstructured":"Ver Donck L, Borgers M, Verdonck F. Inhibition of sodium and calcium overload pathology in the myocardium: a new cytoprotective principle. Cardiovasc Res. 1993;27(3):349-57. https:\/\/doi.org\/10.1093\/cvr\/27.3.349","journal-title":"Cardiovasc Res."},{"issue":"2","key":"6479_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.pharmthera.2008.04.004","volume":"119","author":"L Carlsson","year":"2008","unstructured":"Carlsson L. The anaesthetised methoxamine-sensitised rabbit model of torsades de pointes. Pharmacol Ther. 2008;119(2):160-7. https:\/\/doi.org\/10.1016\/j.pharmthera.2008.04.004","journal-title":"Pharmacol Ther."},{"issue":"1\u20133","key":"6479_CR16","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ejphar.2006.03.014","volume":"537","author":"AS Farkas","year":"2006","unstructured":"Farkas AS, Acsai K, T\u00f3th A, et al. Importance of extracardiac alpha1-adrenoceptor stimulation in assisting dofetilide to induce torsade de pointes in rabbit hearts. Eur J Pharmacol. 2006;537(1-3):118-25. https:\/\/doi.org\/10.1016\/j.ejphar.2006.03.014","journal-title":"Eur J Pharmacol."},{"key":"6479_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1113\/jphysiol.1984.sp015228","volume":"351","author":"TM Griffith","year":"1984","unstructured":"Griffith TM, Henderson AH, Edwards DH, et al. Isolated perfused rabbit coronary artery and aortic strip preparations: the role of endothelium-derived relaxant factor. J Physiol. 1984;351:13-24. https:\/\/doi.org\/10.1113\/jphysiol.1984.sp015228","journal-title":"J Physiol."},{"issue":"7","key":"6479_CR18","doi-asserted-by":"publisher","first-page":"5093","DOI":"10.1007\/s00210-023-02940-5","volume":"397","author":"DV Abramochkin","year":"2024","unstructured":"Abramochkin DV, Pustovit OB, Mironov NY, et al. Characterization of hERG K+ channel inhibition by the new class III antiarrhythmic drug cavutilide. Naunyn Schmiedebergs Arch Pharmacol. 2024;397(7):5093-104. https:\/\/doi.org\/10.1007\/s00210-023-02940-5","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"issue":"5","key":"6479_CR19","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s10517-023-05756-8","volume":"174","author":"DV Abramochkin","year":"2023","unstructured":"Abramochkin DV, Pustovit OB, Mironov NY, et al. The dependence of the electrophysiological effects of class III antiarrhythmic drug refralon on the frequency of myocardium activation. Bull Exp Biol Med. 2023;174(5):610-5. https:\/\/doi.org\/10.1007\/s10517-023-05756-8","journal-title":"Bull Exp Biol Med."}],"container-title":["Bulletin of Experimental Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-025-06479-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10517-025-06479-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-025-06479-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T15:17:52Z","timestamp":1759763872000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10517-025-06479-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["6479"],"URL":"https:\/\/doi.org\/10.1007\/s10517-025-06479-8","relation":{},"ISSN":["0007-4888","1573-8221"],"issn-type":[{"type":"print","value":"0007-4888"},{"type":"electronic","value":"1573-8221"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"18 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}